234 related articles for article (PubMed ID: 27309677)
1. Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism.
Zhang Z; Gou Y; Wang J; Yang K; Qi J; Zhou Z; Liang S; Liang H; Yang F
Eur J Med Chem; 2016 Oct; 121():399-409. PubMed ID: 27309677
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism.
Qi J; Liang S; Gou Y; Zhang Z; Zhou Z; Yang F; Liang H
Eur J Med Chem; 2015; 96():360-8. PubMed ID: 25899339
[TBL] [Abstract][Full Text] [Related]
3. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
[TBL] [Abstract][Full Text] [Related]
4. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
5. Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands.
Deng J; Yu P; Zhang Z; Wang J; Cai J; Wu N; Sun H; Liang H; Yang F
Eur J Med Chem; 2018 Oct; 158():442-452. PubMed ID: 30241011
[TBL] [Abstract][Full Text] [Related]
6. Doubly chloro bridged dimeric copper(II) complex: magneto-structural correlation and anticancer activity.
Sikdar Y; Modak R; Bose D; Banerjee S; Bieńko D; Zierkiewicz W; Bieńko A; Das Saha K; Goswami S
Dalton Trans; 2015 May; 44(19):8876-88. PubMed ID: 25871579
[TBL] [Abstract][Full Text] [Related]
7. Two new Cu(II) dipeptide complexes based on 5-methyl-2-(2'-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: Special exploration of their possible anticancer mechanism.
Qi YY; Gan Q; Liu YX; Xiong YH; Mao ZW; Le XY
Eur J Med Chem; 2018 Jun; 154():220-232. PubMed ID: 29803995
[TBL] [Abstract][Full Text] [Related]
8. Cu(II), Ni(II) complexes derived from chiral Schiff-base ligands: Synthesis, characterization, cytotoxicity, protein and DNA-binding properties.
Li Z; Yan H; Chang G; Hong M; Dou J; Niu M
J Photochem Photobiol B; 2016 Oct; 163():403-12. PubMed ID: 27619741
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of apoptosis induction in K562 and KG1a leukemia cells by a water-soluble copper(II) thiosemicarbazone complex.
Parsa FG; Feizi MAH; Safaralizadeh R; Hosseini-Yazdi SA; Mahdavi M
J Biol Inorg Chem; 2020 May; 25(3):383-394. PubMed ID: 32274578
[TBL] [Abstract][Full Text] [Related]
10. Monitoring cellular uptake and cytotoxicity of copper(II) complex using a fluorescent anthracene thiosemicarbazone ligand.
Kate AN; Kumbhar AA; Khan AA; Joshi PV; Puranik VG
Bioconjug Chem; 2014 Jan; 25(1):102-14. PubMed ID: 24328322
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle arrest in cultured neuroblastoma cells exposed to a bis(thiosemicarbazonato) metal complex.
Bica L; Meyerowitz J; Parker SJ; Caragounis A; Du T; Paterson BM; Barnham KJ; Crouch PJ; White AR; Donnelly PS
Biometals; 2011 Feb; 24(1):117-33. PubMed ID: 20931265
[TBL] [Abstract][Full Text] [Related]
12. Identification of differential anti-neoplastic activity of copper bis(thiosemicarbazones) that is mediated by intracellular reactive oxygen species generation and lysosomal membrane permeabilization.
Stefani C; Al-Eisawi Z; Jansson PJ; Kalinowski DS; Richardson DR
J Inorg Biochem; 2015 Nov; 152():20-37. PubMed ID: 26335599
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antiproliferative activity and mechanism of gallium(III)-thiosemicarbazone complexes as potential anti-breast cancer agents.
Qi J; Yao Q; Qian K; Tian L; Cheng Z; Yang D; Wang Y
Eur J Med Chem; 2018 Jun; 154():91-100. PubMed ID: 29777989
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands.
Rogolino D; Cavazzoni A; Gatti A; Tegoni M; Pelosi G; Verdolino V; Fumarola C; Cretella D; Petronini PG; Carcelli M
Eur J Med Chem; 2017 Mar; 128():140-153. PubMed ID: 28182987
[TBL] [Abstract][Full Text] [Related]
15. L- and D-proline thiosemicarbazone conjugates: coordination behavior in solution and the effect of copper(II) coordination on their antiproliferative activity.
Milunovic MN; Enyedy É; Nagy NV; Kiss T; Trondl R; Jakupec MA; Keppler BK; Krachler R; Novitchi G; Arion VB
Inorg Chem; 2012 Sep; 51(17):9309-21. PubMed ID: 22889304
[TBL] [Abstract][Full Text] [Related]
16. New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity.
Zaltariov MF; Hammerstad M; Arabshahi HJ; Jovanović K; Richter KW; Cazacu M; Shova S; Balan M; Andersen NH; Radulović S; Reynisson J; Andersson KK; Arion VB
Inorg Chem; 2017 Mar; 56(6):3532-3549. PubMed ID: 28252952
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones.
Da Silva JG; Recio Despaigne AA; Louro SR; Bandeira CC; Souza-Fagundes EM; Beraldo H
Eur J Med Chem; 2013 Jul; 65():415-26. PubMed ID: 23747809
[TBL] [Abstract][Full Text] [Related]
18. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
[TBL] [Abstract][Full Text] [Related]
19. Increased generation of intracellular reactive oxygen species initiates selective cytotoxicity against the MCF-7 cell line resultant from redox active combination therapy using copper-thiosemicarbazone complexes.
Akladios FN; Andrew SD; Parkinson CJ
J Biol Inorg Chem; 2016 Jun; 21(3):407-19. PubMed ID: 26951232
[TBL] [Abstract][Full Text] [Related]
20. α-N-heterocyclic thiosemicarbazone Fe(III) complex: Characterization of its antitumor activity and identification of anticancer mechanism.
Gou Y; Wang J; Chen S; Zhang Z; Zhang Y; Zhang W; Yang F
Eur J Med Chem; 2016 Nov; 123():354-364. PubMed ID: 27487566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
